把厂商材料、合成 benchmark、临床安全评估和 FDA CDS 适用性分开,再为医疗 Agent 建立动作级风险、审批和终态验收账本。
Separate vendor claims, synthetic benchmarks, clinical safety reviews, and FDA CDS applicability before authorizing healthcare computer-use actions.
从动作盘点、审批工单到异常分流与终态验收,给遗留门户 Computer Use Agent 建立可执行的风险控制面。
A practical action-risk matrix for legacy-portal agents, with executor-side approval, bounded autonomy, and verified business outcomes.